Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$619M |
| 2 |
Citigroup
C
|
+$457M |
| 3 |
Cimpress
CMPR
|
+$379M |
| 4 |
Broadcom
AVGO
|
+$374M |
| 5 |
Apple
AAPL
|
+$287M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RAI
Reynolds American Inc
RAI
|
+$348M |
| 2 |
Microsoft
MSFT
|
+$331M |
| 3 |
IQVIA
IQV
|
+$243M |
| 4 |
Costco
COST
|
+$193M |
| 5 |
St. Joe Company
JOE
|
+$168M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.21% |
| 2 | Healthcare | 15.34% |
| 3 | Financials | 13.77% |
| 4 | Industrials | 12.77% |
| 5 | Consumer Discretionary | 10.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
Archer Daniels Midland
ADM
$41.4B
| $14.4M | 0.01% |
338,949
-211,457
| -38% | -$8.91M |
|
802
Yext
YEXT
$501M
| $14.3M | 0.01% |
1,078,927
-11,359
| -1% | -$151K |
|
803
NXP Semiconductors
NXPI
$68B
| $14.3M | 0.01% |
126,652
+26,418
| +26% | +$2.95M |
|
804
Stride
LRN
$3.69B
| $14.3M | 0.01% |
802,478
+758,100
| +1,708% | +$13.4M |
|
805
Akamai
AKAM
$16.8B
| $14.3M | 0.01% |
292,768
-909,342
| -76% | -$43.5M |
|
806
Axos Financial
AX
$5.45B
| $14.3M | 0.01% |
500,589
-152,767
| -23% | -$3.99M |
|
807
Aaon
AAON
$8.41B
| $14.2M | 0.01% |
619,650
-73,511
| -11% | -$1.67M |
|
808
Factset
FDS
$9.05B
| $14.2M | 0.01% |
78,693
-109,869
| -58% | -$17.9M |
|
809
Phillips 66
PSX
$82.9B
| $13.9M | 0.01% |
151,618
-114,123
| -43% | -$9.67M |
|
810
Campbell Soup
CPB
$6.51B
| $13.5M | 0.01% |
287,709
-66,943
| -19% | -$3.39M |
|
811
Markel Group
MKL
$25B
| $13.5M | 0.01% |
12,609
-2,094
| -14% | -$2.17M |
|
812
Capital One
COF
$124B
| $13.4M | 0.01% |
158,640
+5,781
| +4% | +$477K |
|
813
Infosys
INFY
$45B
| $13M | 0.01% |
1,785,168
+47,526
| +3% | +$360K |
|
|
SP
814
DELISTED
SP Plus Corporation
SP
| $12.9M | 0.01% |
327,463
-148,468
| -31% | -$5.22M |
|
|
CMTA
815
DELISTED
Clementia Pharmaceuticals Inc.
CMTA
| $12.8M | 0.01% |
+759,792
| New | +$12.4M |
|
|
ALDR
816
DELISTED
Alder Biopharmaceuticals
ALDR
| $12.8M | 0.01% |
1,047,267
-2,180,291
| -68% | -$22.7M |
|
|
HR
817
DELISTED
Healthcare Realty Trust Incorporated
HR
| $12.7M | 0.01% |
391,942
+31,807
| +9% | +$1.05M |
|
|
ELLI
818
DELISTED
Ellie Mae Inc
ELLI
| $12.6M | 0.01% |
153,574
-46,380
| -23% | -$4.26M |
|
819
Dollar General
DG
$25.9B
| $12.6M | 0.01% |
155,511
-1,550,398
| -91% | -$116M |
|
820
Hubbell
HUBB
$25.7B
| $12.6M | 0.01% |
108,355
-83,881
| -44% | -$9.61M |
|
|
NUVA
821
DELISTED
NuVasive, Inc.
NUVA
| $12.5M | 0.01% |
225,655
+61,742
| +38% | +$4.09M |
|
822
Grand Canyon Education
LOPE
$3.71B
| $12.3M | 0.01% |
135,614
+58,624
| +76% | +$4.7M |
|
|
ATRI
823
DELISTED
Atrion Corp
ATRI
| $12.2M | 0.01% |
18,218
-3,387
| -16% | -$2.17M |
|
824
H&R Block
HRB
$5.18B
| $12.2M | 0.01% |
462,011
+147,128
| +47% | +$4.27M |
|
825
Monolithic Power Systems
MPWR
$65.5B
| $12.2M | 0.01% |
114,189
-33,554
| -23% | -$3.41M |
|
Similar funds
Janus Henderson Group's Q3 2017 Portfolio in Review
As of Q3 2017, Janus Henderson Group held 1,386 positions worth $156B, up 5.9% from $147B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Janus Henderson Group's Q3 2017 filing shows 78 new, 598 increased, 569 reduced and 102 closed positions. Its largest new stake was Medtronic: 7,457,362 shares worth $580M. The largest sale was Reynolds American Inc, an estimated $348M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- Janus Henderson Group's largest Q3 2017 buy was Medtronic: 7,457,362 shares worth $580M.
- Janus Henderson Group added most to Citigroup in Q3 2017, an estimated $457M increase.
- Janus Henderson Group's biggest Q3 2017 reduction was Microsoft, cutting an estimated $331M.
- Janus Henderson Group fully exited Reynolds American Inc in Q3 2017, selling an estimated $348M.
- Janus Henderson Group's ten largest holdings make up 14% of its $156B portfolio in Q3 2017.
- Janus Henderson Group opened 78 new positions and closed 102 in Q3 2017.
- Janus Henderson Group's portfolio value rose 5.9% quarter-over-quarter to $156B.
Based on Janus Henderson Group's 13F filing for Q3 2017, filed 14 Nov 2017.